2-(2-Amino-4-methylsulfanyl-butyrylamino)-3-methyl-pentanoic acid | 93060-78-7

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 2-(2-Amino-4-methylsulfanyl-butyrylamino)-3-methyl-pentanoic acid
• 英文别名: 2-[(2-azaniumyl-4-methylsulfanylbutanoyl)amino]-3-methylpentanoate
• CAS: 93060-78-7
• 化学式: C₁₁H₂₂N₂O₃S
• 分子量: 262.373
• InChiKey: OGGRSJFVXREKOR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.5
• 重原子数：
  17
• 可旋转键数：
  7
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.82
• 拓扑面积：
  122
• 氢给体数：
  2
• 氢受体数：
  4

文献信息

• Biomarkers of recurrent Clostridium difficile infection
  申请人：Baylor College of Medicine

  公开号：US10280470B2

  公开（公告）日：2019-05-07

  Embodiments of the invention include methods and/or compositions for analysis of samples for C. difficile infection to determine whether or not an individual is at risk for having recurrent C. difficile infection or a CDI misdiagnosis. Methods include characterization of microflora composition from the gut, wherein alterations of the microflora gut composition are indicative of recurrence of infection. Methods include analysis of nucleic acids from the gut, such as 16S rRNA as being identifying of a particular bacteria in the analysis of bacterial populations of the gut.

  本发明的实施方案包括用于分析艰难梭菌感染样本的方法和/或组合物，以确定个体是否有反复感染艰难梭菌或被误诊为艰难梭菌感染的风险。方法包括鉴定肠道微生物菌群组成，其中肠道微生物菌群组成的改变表明感染复发。方法包括分析来自肠道的核酸，如 16S rRNA，作为分析肠道细菌种群中特定细菌的标识。
• METHODS AND USES FOR METABOLIC PROFILING FOR CLOSTRIDIUM DIFFICILE INFECTION
  申请人：The Board of Regents of The University of Texas System

  公开号：EP2776829A1

  公开（公告）日：2014-09-17
• BIOMARKERS OF RECURRENT CLOSTRIDIUM DIFFICILE INFECTION
  申请人：BAYLOR COLLEGE OF MEDICINE

  公开号：US20150344940A1

  公开（公告）日：2015-12-03

  Embodiments of the invention include methods and/or compositions for analysis of samples for C. difficile infection to determine whether or not an individual is at risk for having recurrent C. difficile infection or a CDI misdiagnosis. Methods include characterization of microflora composition from the gut, wherein alterations of the microflora gut composition are indicative of recurrence of infection. Methods include analysis of nucleic acids from the gut, such as 16S rRNA as being identifying of a particular bacteria in the analysis of bacterial populations of the gut.
• [EN] METHODS AND USES FOR METABOLIC PROFILING FOR CLOSTRIDIUM DIFFICILE INFECTION<br/>[FR] PROCÉDÉS ET UTILISATIONS DE PROFILAGE MÉTABOLIQUE POUR UNE INFECTION PAR CLOSTRIDIUM DIFFICILE (CDI)
  申请人：UNIV TEXAS

  公开号：WO2013070962A1

  公开（公告）日：2013-05-16

  Embodiments include methods for generating a metabolite profile of a stool sample and methods of assessing the status of a subject using the metabolic profile derived from a stool sample.
• [EN] BIOMARKERS OF RECURRENT CLOSTRIDIUM DIFFICILE INFECTION<br/>[FR] BIOMARQUEURS D'UNE INFECTION RÉCURRENTE PAR CLOSTRIDIUM DIFFICILE
  申请人：BAYLOR COLLEGE MEDICINE

  公开号：WO2014110493A1

  公开（公告）日：2014-07-17

  Embodiments of the invention include methods and/or compositions for analysis of samples for C. difficile infection to determine whether or not an individual is at risk for having recurrent C. difficile infection or a CDI misdiagnosis. Methods include characterization of microflora composition from the gut, wherein alterations of the microflora gut composition are indicative of recurrence of infection. Methods include analysis of nucleic acids from the gut, such as 16S rRNA as being identifying of a particular bacteria in the analysis of bacterial populations of the gut.